SCHEMBL30558282

SCHEMBL30558282

COC(=O)Cc1ccc(NC(=O)OC(C)(C)C)cc1Br

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 2/20 0.45
MTNR1B P49286 2/20 0.45
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA9 Q16790 1/20 0.43
CYP17A1 P05093 1/20 0.41
PPARG P37231 3/20 0.41
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
PPARA Q07869 1/20 0.40
KDM4E B2RXH2 1/20 0.40
KMT2A Q03164 1/20 0.40
HDAC3 O15379 2/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC2 Q92769 2/20 0.39
HDAC8 Q9BY41 2/20 0.39
HDAC6 Q9UBN7 1/20 0.39
MMP8 P22894 2/20 0.38
MMP3 P08254 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20157848 0.85 CA12 (0.45) CA12CA1CA9CYP17A1ALDH1A1
SCHEMBL27690605 0.84 CA1 (0.44) CA12CA1CA9CYP17A1ALDH1A1
SCHEMBL23164348 0.80 ALDH1A1 (0.48) CA12CA1CA9CYP17A1ALDH1A1
SCHEMBL31292271 0.80 MTNR1A (0.43) MTNR1AMTNR1BCA1GAAHDAC1
SCHEMBL7341428 0.78 ALDH1A1 (0.41) CA12CA1CA9CYP17A1ALDH1A1
SCHEMBL31679547 0.78 ALDH1A1 (0.56) CA12CA1CA9ALDH1A1GAA
SCHEMBL8708428 0.78 ALDH1A1 (0.56) CA12CA1CA9ALDH1A1GAA
SCHEMBL6096909 0.77 CA1 (0.48) CA12CA1CA9CYP17A1ALDH1A1
SCHEMBL15538944 0.77 SMN1; SMN2 (0.59) CYP17A1PPARGALDH1A1PPARAKDM4E
SCHEMBL4612314 0.77 CA12 (0.48) CA12CA1CA9CYP17A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023155873-A1 CARBOXYLIC ACID COMPOUND, METHOD FOR PREPARING SAME, AND USE THEREOF IN PHARMACEUTICS 江苏恒瑞医药股份有限公司 2023-08-24 WO disclosed